Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Federal Trade Commission
Chinese Patent Office

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072205

« Back to Dashboard

NDA 072205 describes LOXAPINE SUCCINATE, which is a drug marketed by Elite Labs Inc, Lannett Holdings Inc, Mylan, and Watson Labs, and is included in seven NDAs. It is available from ten suppliers. Additional details are available on the LOXAPINE SUCCINATE profile page.

The generic ingredient in LOXAPINE SUCCINATE is loxapine succinate. There are eight drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the loxapine succinate profile page.
Summary for 072205
Applicant:Watson Labs
Ingredient:loxapine succinate
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 072205
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 072205 ANDA Actavis Pharma, Inc. 0591-0370 0591-0370-01 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-0370-01)
LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 072205 ANDA REMEDYREPACK INC. 70518-0283 70518-0283-0 30 CAPSULE in 1 BLISTER PACK (70518-0283-0)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 10MG BASE
Approval Date:Jun 15, 1988TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Express Scripts
US Army
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.